XML 56 R45.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Information (Sales And Other Financial Information By Business Segment) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Segment Reporting Information [Line Items]        
Net sales $ 4,909 $ 4,479 $ 14,683 $ 13,247
Segment operating income 931 808 2,631 2,027
Amortization of intangible assets (164) (159) (486) (469)
Recall-related matters (9) 4 (12) (14)
MedSurg and Neurotechnology        
Segment Reporting Information [Line Items]        
Net sales 2,859 2,588 8,409 7,560
Orthopaedics and Spine        
Segment Reporting Information [Line Items]        
Net sales 2,050 1,891 6,274 5,687
Operating Segments        
Segment Reporting Information [Line Items]        
Segment operating income 1,358 1,145 3,967 3,486
Operating Segments | MedSurg and Neurotechnology        
Segment Reporting Information [Line Items]        
Net sales 2,859 2,588    
Segment operating income 859 611 2,266 1,870
Operating Segments | Orthopaedics and Spine        
Segment Reporting Information [Line Items]        
Net sales 2,050 1,891 6,274 5,687
Segment operating income 499 534 1,701 1,616
Corporate and other        
Segment Reporting Information [Line Items]        
Segment operating income (209) (144) (596) (488)
Segment Reconciling Items        
Segment Reporting Information [Line Items]        
Acquisition and integration-related costs 1 78 (7) (108)
Amortization of intangible assets (164) (159) (486) (469)
Structural optimization and other special charges (28) (58) (142) (229)
Medical device regulations (19) (38) (74) (98)
Recall-related matters (9) 4 (12) (14)
Regulatory and legal matters $ 1 $ (20) $ (19) $ (53)